Table 3.
Diagnosis, n (%) | Total, n (%) | ||||||||
---|---|---|---|---|---|---|---|---|---|
Unspecified | Other | AOM | URTI | Sinusitis | Pneumonia | Bronchitis | |||
Serotype | None | 27 (5.1) | 7 (1.3) | 41 (7.7) | 384 (72.0) | 13 (2.4) | 10 (1.9) | 51 (9.6) | 533 (59.2) |
Othera | 1 (4.0) | 0 (0.0) | 3 (12.0) | 13 (52.0) | 4 (16.0) | 1 (4.0) | 3 (12.0) | 25 (2.7) | |
11 | 0 (0.0) | 2 (11.8) | 0 (0.0) | 9 (52.9) | 0 (0.0) | 0 (0.0) | 6 (35.3) | 17 (1.9) | |
14 | 2 (5.7) | 0 (0.0) | 3 (8.6) | 15 (42.9) | 2 (5.7) | 5 (14.3) | 8 (22.9) | 35 (3.8) | |
15b | 2 (5.4) | 0 (0.0) | 3 (8.1) | 25 (67.6) | 1 (2.7) | 2 (5.4) | 4 (10.8) | 37 (4.1) | |
18C | 2 (18.2) | 0 (0.0) | 2 (18.2) | 5 (45.5) | 1 (9.1) | 0 (0.0) | 1 (9.1) | 11 (1.2) | |
19A | 1 (12.5) | 1 (12.5) | 0 (0.0) | 4 (50.0) | 1 (12.5) | 0 (0.0) | 1 (12.5) | 8 (0.9) | |
19F | 4 (7.8) | 0 (0.0) | 9 (17.6) | 25 (49.0) | 3 (5.9) | 1 (2.0) | 9 (17.6) | 51 (5.6) | |
23c | 0 (0.0) | 0 (0.0) | 0 (0.0) | 5 (50.0) | 3 (30.0) | 0 (0.0) | 2 (20.0) | 10 (1.1) | |
23F | 1 (2.0) | 0 (0.0) | 1 (2.0) | 35 (68.6) | 5 (9.8) | 2 (3.9) | 7 (13.7) | 51 (5.7) | |
3 | 1 (9.1) | 0 (0.0) | 3 (27.3) | 4 (36.4) | 1 (9.1) | 0 (0.0) | 2 (18.2) | 11 (1.2) | |
6A | 2 (5.9) | 0 (0.0) | 6 (17.6) | 19 (55.9) | 1 (2.9) | 1 (2.9) | 5 (14.7) | 34 (3.8) | |
6B | 3 (5.2) | 2 (3.4) | 4 (6.9) | 33 (56.9) | 1 (1.7) | 2 (3.4) | 13 (22.4) | 58 (6.4) | |
Non-typable | 1 (5.2) | 0 (0.0) | 1 (5.3) | 16 (84.2) | 0 (0.0) | 0 (0.0) | 1 (5.2) | 19 (2.1) | |
Total, n (%) | 47 (5.2) | 12 (1.3) | 76 (8.4) | 592 (65.8) | 36 (4.0) | 24 (2.7) | 113 (12.6) | 900 (100.0) | |
Antimicrobial use, n (%) | 14 (29.7) | 3 (25.0) | 55 (72.4) | 173 (29.2) | 32 (88.8) | 23 (95.8) | 61 (12.6) | 361 (40.1) |
AOM acute otitis media, URTI upper respiratory tract infection
aCombined cases of SPn serotypes 4, 7, 7F, 6C, 9, 9V, 10, 12, 17, 19, 22
bSerogroup 15
cNon-23F serotypes